EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide

Batoul Makiabadi, Fereshteh Naderi iD, Mohammad Zakarianezhad, Aria Raessi

Nanoscale Advances · 2026 · 8 (15) · 4347-4361

DOI: 10.1039/d5na01168j ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale Advances, 2026. Verfasst von Batoul Makiabadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Sirjan University of Technology Sirjan Iran. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interaction of cyclic peptides with pyrazinamide holds promise for their use as stable and biocompatible carriers for controlled drug delivery in the treatment of tuberculosis.

Autor:innen und Institutionen

  • Department of Chemical Engineering, Sirjan University of Technology Sirjan Iran.
  • Department of Chemistry, ShQ.C., Islamic Azad University Shahr-e Qods Iran fnaderi@iau.ac.ir.
  • Department of Chemistry, Payame Noor University (pnu) P. O. Box 19395-4697 Tehran Iran.
  • Faculty of Medicine, University of Debrecen 4032 Debrecen Hungary.

ORCID-Profile: Fereshteh Naderi

Zitieren

APA

Makiabadi, B., Naderi, F., Zakarianezhad, M., & Raessi, A. (2026). Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide. Nanoscale Advances, 8(15), 4347-4361. https://doi.org/10.1039/d5na01168j

Vancouver

Makiabadi B, Naderi F, Zakarianezhad M, Raessi A. Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide. Nanoscale Advances. 2026;8(15):4347-4361. doi:10.1039/d5na01168j

BibTeX
@article{Makiabadi2026,
  author = {Makiabadi, Batoul and Naderi, Fereshteh and Zakarianezhad, Mohammad and Raessi, Aria},
  title = {Investigation of cyclic peptides as drug delivery systems for the delivery of the anti-tuberculosis drug pyrazinamide},
  journal = {Nanoscale Advances},
  year = {2026},
  volume = {8},
  number = {15},
  pages = {4347--4361},
  doi = {10.1039/d5na01168j}
}
Kostenlos starten →